The Department of Surgery is committed to excellence in research, in order to find new and better treatments for our patients, as part of our commitment to excellence in patient care.
We currently are performing a variety of clinical trials to evaluate the effectiveness of potentially new treatment options related to the surgical specialties represented by our physicians.
Our goal is to give patients the opportunity to participate in approved and exploratory therapies without long-distance travel.
Participation in our clinical trials is always completely voluntary and
never interferes with the normal standards for patient care.
Our clinical trials enable us to use, in addition to established therapies, the newest and most advanced technologies and treatments — long before they are available to other physicians.
Patients participate in our clinical trials only after they receive a complete explanation of their options from their surgeon and surgical team.
- Abdominal aortic aneurysm. Studying a new endovascular aortic securement system to improve AAA repair grafts (more); contact 631-444-8156.
- Abdominal aortic aneurysm. Studying a new endovascular stent graft to repair AAAs below the kidneys (more); contact 631-444-8156.
- Abdominal aortic, aorto-iliac, and iliac aneurysms. Studying the safety and effectiveness of a stent graft used along with an iliac leg graft to surgically treat abdominal aortic, aorto-iliac, and iliac aneurysms (more); contact 631-444-8156.
- Cellulite. Studying effectiveness of investigational drug (injection) to treat cellulite in women (more).
- Gallbladder surgery. Studying use of new imaging devices for identifying anatomy during laparoscopic surgery for gallbladder removal.
- Iliac vein blockage. Studying the use of sound wave imaging of the inside of the leg veins, in combination with standard x-ray imaging, to gain additional information about the severity and nature of vein blockages (more); contact 631-444-8156.
- Lung cancer. Studying the safety and efficacy of cryoablation therapy used to treat tumors in patients with pulmonary metastatic disease (more).
- Obesity. Studying the safety and efficacy of a swallowed balloon that resides at the top of the stomach to limit appetite and facilitate weight loss; contact 631-444-2274.
- Peripheral arterial disease. Studying a new collagen dressing coated with blood-clotting proteins, compared with the standard dressing used for to control needle-hole bleeding in vascular surgery (more); contact 631-444-8156.
- Peripheral arterial disease. Studying a new topical drug that helps control bleeding at the site where arteries are sewn together, compared with the standard treatment of hand compression with gauze or pad (more); contact 631-444-8156.
- Peripheral endovascular interventions. Studying a novel anticoagulation drug to determine whether its use results in fewer major bleeding complications compared with unfractionated heparin in patients undergoing peripheral endovascular surgery (more); contact 631-444-8156.
- Pulmonary embolism. Studying a temporary or permanent placed vein filter for patients who need to prevent blood clots forming in the lungs because they can't take anticlotting "blood thinner" medicines (more); contact 631-444-8156.
- Soft tissue cancer. Studying effect of flu vaccine on immune system in patients undergoing cancer surgery.
For more information about our current clinical trials, call our research coordinator Leah Smith-McAllister at 631-444-7230.